false
0001468492
0001468492
2026-11-19
2026-11-19
0001468492
us-gaap:CommonStockMember
2026-11-19
2026-11-19
0001468492
HSCS:WarrantsMember
2026-11-19
2026-11-19
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported):
November 19, 2026
HeartSciences Inc.
(Exact name of Registrant as Specified in Its
Charter)
| Texas |
|
001-41422 |
|
26-1344466 |
(State or Other Jurisdiction
of Incorporation) |
|
(Commission File Number) |
|
(IRS Employer
Identification No.) |
|
550 Reserve Street, Suite 360
Southlake, Texas |
|
76092 |
| (Address of Principal Executive Offices) |
|
(Zip Code) |
Registrant’s Telephone Number, Including
Area Code: (682) 237-7781
(Former Name or Former Address, if Changed Since
Last Report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ | Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b)
of the Act:
| Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
| Common Stock |
|
HSCS |
|
The Nasdaq Stock Market LLC |
| Warrants |
|
HSCSW |
|
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
Item 5.07 Submission of Matters to a Vote of Security Holders.
On November 19, 2026, HeartSciences
Inc. (the “Company”) held a special meeting of shareholders (the “Special Meeting”). At the Special Meeting, the
Company’s shareholders voted on the proposals described below. The proposals presented at the Special Meeting are described in detail
in the Company’s definitive proxy statement for the Special Meeting filed with the U.S. Securities and Exchange Commission (the
“SEC”) on October 19, 2026 (the “Proxy Statement”), as supplemented by the Company’s Current Report on Form
8-K filed by the Company on November 6, 2026 and the Company’s definitive additional materials on Schedule 14A filed by the Company
on November 10, 2026 relating to the Proxy Statement. Capitalized terms used but not otherwise defined herein have the meanings given
to them in the Proxy Statement.
Of the 4,949,283 shares of
the Company’s common stock, $0.001 par value per share (the “common stock”), outstanding and 343,516 shares of common
stock issuable upon the conversion of 380,440 shares of Series C Convertible Preferred Stock, $0.001 par value per share (the “Series
C Preferred Stock”), outstanding, each as of October 8, 2026 (the “Record Date”) and entitled to vote at the Special
Meeting, 4,041,647, or 76.36%, of the shares entitled to vote were present virtually or by proxy. Accordingly, a quorum was present at
the Special Meeting.
The results for each of the
proposals submitted to a vote of shareholders at the Special Meeting are as follows:
Proposal 1: The Combination Proposal
The Company’s shareholders
voted as follows with respect to the proposal to approve the Agreement and Plan of Merger (as amended on July 27, 2026 and as it may be
further amended from time to time, the “Merger Agreement”) and the transactions contemplated therein (collectively, the “Transactions”)
pursuant to the Texas Business Organizations Code:
| For | | |
Against | | |
Abstained | | |
Broker Non-Votes | |
| | 3,480,989 | | |
| 20,933 | | |
| 3,150 | | |
| 536,575 | |
Proposal 2: The Nasdaq Proposal
The Company’s shareholders
voted as follows with respect to the proposal to approve (a) the issuance of shares of Class V Common Stock as contemplated by the Merger
Agreement, (b) the issuance of shares of Class A Common Stock as contemplated by the Merger Agreement, (c) for the purpose of raising
additional cash for the Combined Company and/or increasing the public float of Class A Common Stock, the additional issuance of up to
an aggregate of 35,000,000 shares of Class A Common Stock issued (i) in one or more private placements of Class A Common Stock completed
within one month of the Closing, (ii) pursuant to the conversion or exercise of debt or equity securities issued by the Company, Fortitude
or Fortitude HoldCo in one or more private placements completed within one month of the Closing and which securities are convertible into
or exercisable for Class A Common Stock, and/or (iii) pursuant to the exchange of indebtedness of the Company, Fortitude or Fortitude
HoldCo that is outstanding prior to the Closing into Class A Common Stock in a private transaction completed within one month of the Closing,
with total aggregate consideration, in the form of cash, Zcash or the satisfaction of indebtedness, not to exceed $100,000,000, and with
such purchase price, conversion rate or exchange rate, as applicable, subject to a maximum discount of 20% to the market price of the
common stock, and (d) the change of control of the Company resulting from the Transactions, pursuant to Nasdaq Listing Rules 5635(a),
5635(b) and 5635(d):
| For | | |
Against | | |
Abstained | | |
Broker Non-Votes | |
| | 3,459,400 | | |
| 43,445 | | |
| 2,228 | | |
| 536,574 | |
Proposals 3A-G: The Charter Adoption Proposals
The Company’s shareholders
voted on the following proposals to approve and adopt the amendments to the Amended and Restated Certificate of Formation of the Company
set forth in the Second Amended and Restated Certificate of Formation of the Company, the form of which was attached to the Proxy Statement
as Annex B:
Proposal 3A
The Company’s shareholders
voted as follows with respect to Proposal 3A, to change the name of the Company to “Fortitude Mining Group, Inc.”:
| For | | |
Against | | |
Abstained | |
| | 3,987,307 | | |
| 39,842 | | |
| 14,496 | |
Proposal 3B
The Company’s shareholders
voted as follows with respect to Proposal 3B, to change the par value of the authorized common stock of the Company to $0.0001 par value
per share:
| For | | |
Against | | |
Abstained | |
| | 3,958,686 | | |
| 61,217 | | |
| 21,742 | |
Proposal 3C
The Company’s shareholders
voted as follows with respect to Proposal 3C, to designate the Company’s existing class of common stock as “Class A Common
Stock” and designate 350,000,000 shares of the Company’s authorized common stock as Class A Common Stock:
| For | | |
Against | | |
Abstained | | |
Broker Non-Votes | |
| | 3,457,519 | | |
| 35,872 | | |
| 11,682 | | |
| 536,574 | |
Proposal 3D
The Company’s shareholders
voted as follows with respect to Proposal 3D, to establish the terms of the Class V Common Stock and designate 150,000,000 shares of the
Company’s authorized common stock as Class V Common Stock:
| For | | |
Against | | |
Abstained | | |
Broker Non-Votes | |
| | 3,377,858 | | |
| 42,552 | | |
| 84,662 | | |
| 536,575 | |
Proposal 3E
The Company’s shareholders
voted as follows with respect to Proposal 3E, to grant the holders of Class A Common Stock the sole right, voting separately as a single
class, to elect one director, designated by the board of directors of the Company as the “Class A Director”:
| For | | |
Against | | |
Abstained | | |
Broker Non-Votes | |
| | 3,476,116 | | |
| 16,190 | | |
| 12,767 | | |
| 536,574 | |
Proposal 3F
The Company’s shareholders
voted as follows with respect to Proposal 3F, to allow holders representing not less than the minimum number of shares of Combined Company
Common Stock (which are issued, outstanding and entitled to vote) that would be necessary to authorize or take any action at a meeting
of shareholders to take such action by written consent in lieu of a meeting:
| For | | |
Against | | |
Abstained | | |
Broker Non-Votes | |
| | 3,363,152 | | |
| 134,855 | | |
| 7,067 | | |
| 536,573 | |
Proposal 3G
The Company’s shareholders
voted as follows with respect to Proposal 3G, to provide for certain other changes in connection with the amendment and restatement of
the Amended and Restated Certificate of Formation of the Company:
| For | | |
Against | | |
Abstained | | |
Broker Non-Votes | |
| | 3,354,309 | | |
| 135,135 | | |
| 15,630 | | |
| 536,573 | |
Proposal 4: The Reverse Stock Split Proposal
The Company’s shareholders
voted as follows with respect to the proposal to approve an amendment to the Amended and Restated Certificate of Formation of the Company
to effect, at the discretion of the Company’s board of directors (the “Board”), a reverse stock split of the issued
and outstanding common stock at a ratio to be determined by the Board and mutually agreed to by the Company and Fortitude Seller, within
a range of one-for-two through one-for-five, inclusive, in the form attached to the Proxy Statement as Annex H:
| For | | |
Against | | |
Abstained | |
| | 3,981,498 | | |
| 40,735 | | |
| 19,411 | |
Proposal 5: The Plan Amendment Proposal
The Company’s shareholders
voted as follows with respect to the proposal to approve the amendment and restatement of the Company’s equity incentive plan, in
the form attached to the Proxy Statement as Annex C:
| For | | |
Against | | |
Abstained | | |
Broker Non-Votes | |
| | 3,207,036 | | |
| 281,504 | | |
| 16,532 | | |
| 536,575 | |
Proposal 6: The Adjournment Proposal
The Company’s shareholders
voted as follows with respect to the proposal to approve the adjournment of the Special Meeting, if necessary, if a quorum is present,
to solicit additional proxies if there are not sufficient votes at the time of the Special Meeting to approve any of the Proposals presented
for a vote at the Special Meeting.
| For | | |
Against | | |
Abstained | |
| | 3,930,880 | | |
| 103,579 | | |
| 7,184 | |
No other matters were considered
or voted upon at the Special Meeting.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
HEARTSCIENCES INC. |
| |
|
|
| Date: November 19, 2026 |
By: |
/s/ Andrew Simpson |
| |
Name: |
Andrew Simpson |
| |
Title: |
President, Chief Executive Officer, and |
| |
|
Chairman of the Board of Directors |